Export 48 results:
Author Title Type [ Year
Filters: Author is Ferris, Frederick L [Clear All Filters]
“Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort study.”, Bone Marrow Transplant, 2021.
, “Association of Dietary and Supplementary Calcium Intake With Age-Related Macular Degeneration: Age-Related Eye Disease Study Report 39.”, JAMA Ophthalmol, vol. 137, no. 5, pp. 543-550, 2019.
, “The Association of Statin Use with Cataract Progression and Cataract Surgery: The AREDS2 Report Number 8.”, Ophthalmology, vol. 123, no. 4, pp. 916-7, 2016.
, “A Crossover Design for Comparative Efficacy: A 36-Week Randomized Trial of Bevacizumab and Ranibizumab for Diabetic Macular Edema.”, Ophthalmology, vol. 123, no. 4, pp. 841-9, 2016.
, “Evaluating the Validity of the Age-Related Eye Disease Study Grading Scale for Age-Related Macular Degeneration: AREDS2 Report 10.”, JAMA Ophthalmol, vol. 134, no. 9, pp. 1041-7, 2016.
, “The Association of Dietary Lutein plus Zeaxanthin and B Vitamins with Cataracts in the Age-Related Eye Disease Study: AREDS Report No. 37.”, Ophthalmology, vol. 122, no. 7, pp. 1471-9, 2015.
, “The Association of Statin Use with Age-Related Macular Degeneration Progression: The Age-Related Eye Disease Study 2 Report Number 9.”, Ophthalmology, vol. 122, no. 12, pp. 2490-6, 2015.
, “Changes in lens opacities on the age-related eye disease study grading scale predict progression to cataract surgery and vision loss: age-related eye disease study report no. 34.”, Ophthalmology, vol. 122, no. 5, pp. 888-96, 2015.
, “Impairments in Dark Adaptation Are Associated with Age-Related Macular Degeneration Severity and Reticular Pseudodrusen.”, Ophthalmology, vol. 122, no. 10, pp. 2053-62, 2015.
, “Intravitreal sirolimus for the treatment of geographic atrophy: results of a phase I/II clinical trial.”, Invest Ophthalmol Vis Sci, vol. 56, no. 1, pp. 330-8, 2014.
, “Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.”, JAMA Ophthalmol, vol. 132, no. 2, pp. 142-9, 2014.
, “Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36.”, JAMA Ophthalmol, vol. 132, no. 3, pp. 272-7, 2014.
, “Evaluation of optimized digital fundus reflex photographs for lens opacities in the age-related eye disease study 2: AREDS2 report 7.”, Invest Ophthalmol Vis Sci, vol. 54, no. 9, pp. 5989-94, 2013.
, “Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2).”, Invest Ophthalmol Vis Sci, vol. 54, no. 7, pp. 4548-54, 2013.
, “Ten-year incidence rates of age-related cataract in the Age-Related Eye Disease Study (AREDS): AREDS report no. 33.”, Ophthalmic Epidemiol, vol. 20, no. 2, pp. 71-81, 2013.
, “Treatment of geographic atrophy with subconjunctival sirolimus: results of a phase I/II clinical trial.”, Invest Ophthalmol Vis Sci, vol. 54, no. 4, pp. 2941-50, 2013.
, “The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1).”, Ophthalmology, vol. 119, no. 11, pp. 2282-9, 2012.
, “Prevalence of posterior subcapsular cataracts in volunteer cytapheresis donors.”, Transfusion, vol. 51, no. 5, pp. 921-8, 2011.
, “Risk assessment model for development of advanced age-related macular degeneration.”, Arch Ophthalmol, vol. 129, no. 12, pp. 1543-50, 2011.
, “Risk factors associated with incident cataracts and cataract surgery in the Age-related Eye Disease Study (AREDS): AREDS report number 32.”, Ophthalmology, vol. 118, no. 11, pp. 2113-9, 2011.
, “Evaluation of the age-related eye disease study clinical lens grading system AREDS report No. 31.”, Ophthalmology, vol. 117, no. 11, pp. 2112-9.e3, 2010.
, “Natural history of drusenoid pigment epithelial detachment in age-related macular degeneration: Age-Related Eye Disease Study Report No. 28.”, Ophthalmology, vol. 117, no. 3, pp. 489-99, 2010.
, “Preliminary assessment of celecoxib and microdiode pulse laser treatment of diabetic macular edema.”, Retina, vol. 30, no. 3, pp. 459-67, 2010.
, “Progression of geographic atrophy and genotype in age-related macular degeneration.”, Ophthalmology, vol. 117, no. 8, pp. 1554-9, 1559.e1, 2010.
, “Treatment of geographic atrophy by the topical administration of OT-551: results of a phase II clinical trial.”, Invest Ophthalmol Vis Sci, vol. 51, no. 12, pp. 6131-9, 2010.
,